Else-marie M. Loberg
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
Journal: Psychiatry research
Published: December 23, 2025
Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal study.
Journal: Schizophrenia research
Published: August 22, 2025
Levels of and changes in psychosis symptoms and clinical insight: Exploring the impact of differential antipsychotic mechanisms.
Journal: Psychiatry research
Published: April 01, 2025
Low Testosterone Among Males in Opioid Agonist Therapy and Its Association With Fatigue and Psychological Distress.
Journal: Journal of the Endocrine Society
Published: February 27, 2025
Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort.
Journal: Brain, behavior, & immunity - health
Published: August 13, 2024
Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study.
Journal: European addiction research
Published: June 10, 2024
Widespread asymmetries of amygdala nuclei predict auditory verbal hallucinations in schizophrenia.
Journal: BMC psychiatry
Published: April 17, 2024
Reply to a Letter to the Editors From Dr de Souza and colleagues: "Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity".
Journal: Journal of clinical psychopharmacology
Published: December 15, 2023
Associations between happiness with social factors and opioid agonist therapy among people who inject drugs.
Journal: Scientific reports
Published: November 26, 2023
Last Updated: 09/26/2026